Related Experiment Videos
Laboratory diagnosis of atypical pneumonia
1University of Utah School of Medicine, Salt Lake City, USA.
Abstract:
"Atypical pneumonia" is a term loosely applied to lower respiratory tract infections that are not characterized by signs and symptoms of lobar consolidation. This description can apply to disease caused by a variety of bacterial, viral and even protozoan organisms. In reality, differentiation as to etiology of pneumonia cannot be distinguished on the basis of clinical presentation. This review will discuss the epidemiology, clinical manifestations, and laboratory diagnosis of Mycoplasma pneumoniae, Chlamydia sp., Legionella sp., Bordetella pertussis, and Coxiella bumetii, the most common agents associated with atypical pneumonia. Unfortunately, because many of these pathogens are intracellular, culture systems are either not available or the techniques employed are costly, time-consuming or unsafe. Until molecular techniques are standardized and widely available, diagnosis will depend upon serologic confirmation. Given the relative importance of these organisms as causes of community acquired pneumonia, current practice guidelines recommend empiric therapy with a macrolide in patients well enough to be treated as an outpatient. However, diagnostic tests should be performed in any patient requiring hospitalization.
Insights
Atypical pneumonia, caused by various pathogens like Mycoplasma pneumoniae, often requires serologic confirmation for diagnosis. Empiric macrolide therapy is recommended for outpatients, with hospitalization prompting further diagnostic tests.
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Background:
- Atypical pneumonia encompasses lower respiratory tract infections lacking typical lobar consolidation.
- Etiologic differentiation based solely on clinical presentation is challenging.
- Common causative agents include Mycoplasma pneumoniae, Chlamydia sp., Legionella sp., Bordetella pertussis, and Coxiella bumetii.
Purpose of the Study:
- To review the epidemiology, clinical manifestations, and laboratory diagnosis of common atypical pneumonia agents.
- To highlight diagnostic challenges and current recommendations for management.
Main Methods:
- Literature review focusing on Mycoplasma pneumoniae, Chlamydia sp., Legionella sp., Bordetella pertussis, and Coxiella bumetii.
- Discussion of diagnostic methods including culture, serology, and molecular techniques.
- Analysis of current clinical practice guidelines for empiric treatment.
Main Results:
- Many atypical pneumonia pathogens are difficult to culture due to their intracellular nature.
- Serologic confirmation remains a primary diagnostic method in the absence of standardized molecular tests.
- Empiric macrolide therapy is advised for outpatient management of community-acquired pneumonia.
Conclusions:
- Accurate diagnosis of atypical pneumonia relies on a combination of clinical suspicion and appropriate laboratory testing.
- Hospitalized patients with atypical pneumonia require thorough diagnostic evaluation.
- Standardization of molecular diagnostic techniques is crucial for improved patient care.